Breast Tumors

27 registered clinical trials studyying Breast Tumors — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	HealiAid Collagen Wound Dressing in Patients Undergoing Breast Tumor Surgery NCT07209020	Maxigen Biotech Inc.	N/A
Completed	Clinical Study of 18F-FAPI-RGD in Breast Tumors NCT05976620	Sichuan Provincial People's Hospital	—
Recruiting	Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advan NCT06805812	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	—
Recruiting	Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy NCT05582499	Fudan University	Phase 2
Unknown	Therapeutic Dose Monitoring (TDM) of Tamoxifen NCT05133674	Karolinska University Hospital	Phase 2
Completed	A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving NCT05584644	Pfizer	—
Completed	Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis NCT04132960	UNICANCER	Phase 2
Completed	Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment NCT02891681	Washington University School of Medicine	N/A
Completed	Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Canc NCT02187991	US Oncology Research	Phase 2
Completed	A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib W NCT02296801	NSABP Foundation Inc	Phase 2
Terminated	Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer NCT02472353	Avera McKennan Hospital & University Health Center	Phase 2
Completed	Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer NCT01980823	Columbia University	EARLY_Phase 1
Completed	Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated NCT02225470	Eisai Co., Ltd.	Phase 3
Active Not Recruiting	Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than Levobupivac NCT02004834	University Hospital Dubrava	Phase 4
Completed	Simulated Screening Study for Breast Imaging NCT01807754	University of Michigan	—
Terminated	Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer NCT01498588	Emory University	Phase 2
Completed	Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors NCT01218529	Hellenic Cooperative Oncology Group	Phase 2
Terminated	Re-expression of ER in Triple Negative Breast Cancers NCT01194908	Emory University	Phase 1 / Phase 2
Completed	Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer NCT01118624	Acrotech Biopharma Inc.	Phase 2
Recruiting	I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer NCT01042379	QuantumLeap Healthcare Collaborative	Phase 2
Completed	Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer NCT01271738	Emory University	N/A
Completed	Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer NCT00807859	Amgen	Phase 1
Unknown	Biomarker Study of Breast Tumors NCT00941408	National University Hospital, Singapore	—
Completed	QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor P NCT00626106	NantCell, Inc.	Phase 2
Terminated	A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer NCT00356681	Amgen	Phase 2
Completed	Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malign NCT00639171	State University of New York - Upstate Medical University	—
Completed	A Pilot Study Evaluation of the Efficacy of SonoVue to Detect and Characterise Breast Lesions NCT00243698	University Hospital, Tours	N/A